1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hemophilia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 On-demand 1.2.3 Prophylaxis 1.3 Market by Application 1.3.1 Global Hemophilia Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Replacement Therapy 1.3.3 ITI Therapy 1.3.4 Gene Therapy 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hemophilia Treatment Market Perspective (2016-2027) 2.2 Hemophilia Treatment Growth Trends by Regions 2.2.1 Hemophilia Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Hemophilia Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Hemophilia Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Hemophilia Treatment Industry Dynamic 2.3.1 Hemophilia Treatment Market Trends 2.3.2 Hemophilia Treatment Market Drivers 2.3.3 Hemophilia Treatment Market Challenges 2.3.4 Hemophilia Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hemophilia Treatment Players by Revenue 3.1.1 Global Top Hemophilia Treatment Players by Revenue (2016-2021) 3.1.2 Global Hemophilia Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Hemophilia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Hemophilia Treatment Revenue 3.4 Global Hemophilia Treatment Market Concentration Ratio 3.4.1 Global Hemophilia Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hemophilia Treatment Revenue in 2020 3.5 Hemophilia Treatment Key Players Head office and Area Served 3.6 Key Players Hemophilia Treatment Product Solution and Service 3.7 Date of Enter into Hemophilia Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hemophilia Treatment Breakdown Data by Type 4.1 Global Hemophilia Treatment Historic Market Size by Type (2016-2021) 4.2 Global Hemophilia Treatment Forecasted Market Size by Type (2022-2027) 5 Hemophilia Treatment Breakdown Data by Application 5.1 Global Hemophilia Treatment Historic Market Size by Application (2016-2021) 5.2 Global Hemophilia Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Hemophilia Treatment Market Size (2016-2027) 6.2 North America Hemophilia Treatment Market Size by Type 6.2.1 North America Hemophilia Treatment Market Size by Type (2016-2021) 6.2.2 North America Hemophilia Treatment Market Size by Type (2022-2027) 6.2.3 North America Hemophilia Treatment Market Size by Type (2016-2027) 6.3 North America Hemophilia Treatment Market Size by Application 6.3.1 North America Hemophilia Treatment Market Size by Application (2016-2021) 6.3.2 North America Hemophilia Treatment Market Size by Application (2022-2027) 6.3.3 North America Hemophilia Treatment Market Size by Application (2016-2027) 6.4 North America Hemophilia Treatment Market Size by Country 6.4.1 North America Hemophilia Treatment Market Size by Country (2016-2021) 6.4.2 North America Hemophilia Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Hemophilia Treatment Market Size (2016-2027) 7.2 Europe Hemophilia Treatment Market Size by Type 7.2.1 Europe Hemophilia Treatment Market Size by Type (2016-2021) 7.2.2 Europe Hemophilia Treatment Market Size by Type (2022-2027) 7.2.3 Europe Hemophilia Treatment Market Size by Type (2016-2027) 7.3 Europe Hemophilia Treatment Market Size by Application 7.3.1 Europe Hemophilia Treatment Market Size by Application (2016-2021) 7.3.2 Europe Hemophilia Treatment Market Size by Application (2022-2027) 7.3.3 Europe Hemophilia Treatment Market Size by Application (2016-2027) 7.4 Europe Hemophilia Treatment Market Size by Country 7.4.1 Europe Hemophilia Treatment Market Size by Country (2016-2021) 7.4.2 Europe Hemophilia Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Hemophilia Treatment Market Size (2016-2027) 8.2 Asia-Pacific Hemophilia Treatment Market Size by Type 8.2.1 Asia-Pacific Hemophilia Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Hemophilia Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Hemophilia Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Hemophilia Treatment Market Size by Application 8.3.1 Asia-Pacific Hemophilia Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Hemophilia Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Hemophilia Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Hemophilia Treatment Market Size by Region 8.4.1 Asia-Pacific Hemophilia Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Hemophilia Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Hemophilia Treatment Market Size (2016-2027) 9.2 Latin America Hemophilia Treatment Market Size by Type 9.2.1 Latin America Hemophilia Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Hemophilia Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Hemophilia Treatment Market Size by Type (2016-2027) 9.3 Latin America Hemophilia Treatment Market Size by Application 9.3.1 Latin America Hemophilia Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Hemophilia Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Hemophilia Treatment Market Size by Application (2016-2027) 9.4 Latin America Hemophilia Treatment Market Size by Country 9.4.1 Latin America Hemophilia Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Hemophilia Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hemophilia Treatment Market Size (2016-2027) 10.2 Middle East & Africa Hemophilia Treatment Market Size by Type 10.2.1 Middle East & Africa Hemophilia Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Hemophilia Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Hemophilia Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Hemophilia Treatment Market Size by Application 10.3.1 Middle East & Africa Hemophilia Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Hemophilia Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Hemophilia Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Hemophilia Treatment Market Size by Country 10.4.1 Middle East & Africa Hemophilia Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Hemophilia Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 CSL Behring 11.1.1 CSL Behring Company Details 11.1.2 CSL Behring Business Overview 11.1.3 CSL Behring Hemophilia Treatment Introduction 11.1.4 CSL Behring Revenue in Hemophilia Treatment Business (2016-2021) 11.1.5 CSL Behring Recent Development 11.2 Baxalta 11.2.1 Baxalta Company Details 11.2.2 Baxalta Business Overview 11.2.3 Baxalta Hemophilia Treatment Introduction 11.2.4 Baxalta Revenue in Hemophilia Treatment Business (2016-2021) 11.2.5 Baxalta Recent Development 11.3 Pfizer Inc 11.3.1 Pfizer Inc Company Details 11.3.2 Pfizer Inc Business Overview 11.3.3 Pfizer Inc Hemophilia Treatment Introduction 11.3.4 Pfizer Inc Revenue in Hemophilia Treatment Business (2016-2021) 11.3.5 Pfizer Inc Recent Development 11.4 BioMarin 11.4.1 BioMarin Company Details 11.4.2 BioMarin Business Overview 11.4.3 BioMarin Hemophilia Treatment Introduction 11.4.4 BioMarin Revenue in Hemophilia Treatment Business (2016-2021) 11.4.5 BioMarin Recent Development 11.5 Bayer Healthcare 11.5.1 Bayer Healthcare Company Details 11.5.2 Bayer Healthcare Business Overview 11.5.3 Bayer Healthcare Hemophilia Treatment Introduction 11.5.4 Bayer Healthcare Revenue in Hemophilia Treatment Business (2016-2021) 11.5.5 Bayer Healthcare Recent Development 11.6 Biogen 11.6.1 Biogen Company Details 11.6.2 Biogen Business Overview 11.6.3 Biogen Hemophilia Treatment Introduction 11.6.4 Biogen Revenue in Hemophilia Treatment Business (2016-2021) 11.6.5 Biogen Recent Development 11.7 Novo Nordisk 11.7.1 Novo Nordisk Company Details 11.7.2 Novo Nordisk Business Overview 11.7.3 Novo Nordisk Hemophilia Treatment Introduction 11.7.4 Novo Nordisk Revenue in Hemophilia Treatment Business (2016-2021) 11.7.5 Novo Nordisk Recent Development 11.8 Roche 11.8.1 Roche Company Details 11.8.2 Roche Business Overview 11.8.3 Roche Hemophilia Treatment Introduction 11.8.4 Roche Revenue in Hemophilia Treatment Business (2016-2021) 11.8.5 Roche Recent Development 11.9 Takeda 11.9.1 Takeda Company Details 11.9.2 Takeda Business Overview 11.9.3 Takeda Hemophilia Treatment Introduction 11.9.4 Takeda Revenue in Hemophilia Treatment Business (2016-2021) 11.9.5 Takeda Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hemophilia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of On-demand Table 3. Key Players of Prophylaxis Table 4. Global Hemophilia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Hemophilia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Hemophilia Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Hemophilia Treatment Market Share by Regions (2016-2021) Table 8. Global Hemophilia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Hemophilia Treatment Market Share by Regions (2022-2027) Table 10. Hemophilia Treatment Market Trends Table 11. Hemophilia Treatment Market Drivers Table 12. Hemophilia Treatment Market Challenges Table 13. Hemophilia Treatment Market Restraints Table 14. Global Hemophilia Treatment Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Hemophilia Treatment Market Share by Players (2016-2021) Table 16. Global Top Hemophilia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Treatment as of 2020) Table 17. Ranking of Global Top Hemophilia Treatment Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Hemophilia Treatment Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Hemophilia Treatment Product Solution and Service Table 21. Date of Enter into Hemophilia Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Hemophilia Treatment Market Size by Type (2016-2021) (US$ Million) Table 24. Global Hemophilia Treatment Revenue Market Share by Type (2016-2021) Table 25. Global Hemophilia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Hemophilia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Hemophilia Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Hemophilia Treatment Revenue Market Share by Application (2016-2021) Table 29. Global Hemophilia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Hemophilia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Hemophilia Treatment Market Size by Type (2016-2021) (US$ Million) Table 32. North America Hemophilia Treatment Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Hemophilia Treatment Market Size by Application (2016-2021) (US$ Million) Table 34. North America Hemophilia Treatment Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Hemophilia Treatment Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Hemophilia Treatment Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Hemophilia Treatment Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Hemophilia Treatment Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Hemophilia Treatment Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Hemophilia Treatment Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Hemophilia Treatment Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Hemophilia Treatment Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Hemophilia Treatment Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Hemophilia Treatment Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Hemophilia Treatment Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Hemophilia Treatment Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Hemophilia Treatment Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Hemophilia Treatment Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Hemophilia Treatment Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Hemophilia Treatment Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Hemophilia Treatment Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Hemophilia Treatment Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Hemophilia Treatment Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Hemophilia Treatment Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Hemophilia Treatment Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Hemophilia Treatment Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Hemophilia Treatment Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Hemophilia Treatment Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Hemophilia Treatment Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Hemophilia Treatment Market Size by Country (2022-2027) & (US$ Million) Table 61. CSL Behring Company Details Table 62. CSL Behring Business Overview Table 63. CSL Behring Hemophilia Treatment Product Table 64. CSL Behring Revenue in Hemophilia Treatment Business (2016-2021) & (US$ Million) Table 65. CSL Behring Recent Development Table 66. Baxalta Company Details Table 67. Baxalta Business Overview Table 68. Baxalta Hemophilia Treatment Product Table 69. Baxalta Revenue in Hemophilia Treatment Business (2016-2021) & (US$ Million) Table 70. Baxalta Recent Development Table 71. Pfizer Inc Company Details Table 72. Pfizer Inc Business Overview Table 73. Pfizer Inc Hemophilia Treatment Product Table 74. Pfizer Inc Revenue in Hemophilia Treatment Business (2016-2021) & (US$ Million) Table 75. Pfizer Inc Recent Development Table 76. BioMarin Company Details Table 77. BioMarin Business Overview Table 78. BioMarin Hemophilia Treatment Product Table 79. BioMarin Revenue in Hemophilia Treatment Business (2016-2021) & (US$ Million) Table 80. BioMarin Recent Development Table 81. Bayer Healthcare Company Details Table 82. Bayer Healthcare Business Overview Table 83. Bayer Healthcare Hemophilia Treatment Product Table 84. Bayer Healthcare Revenue in Hemophilia Treatment Business (2016-2021) & (US$ Million) Table 85. Bayer Healthcare Recent Development Table 86. Biogen Company Details Table 87. Biogen Business Overview Table 88. Biogen Hemophilia Treatment Product Table 89. Biogen Revenue in Hemophilia Treatment Business (2016-2021) & (US$ Million) Table 90. Biogen Recent Development Table 91. Novo Nordisk Company Details Table 92. Novo Nordisk Business Overview Table 93. Novo Nordisk Hemophilia Treatment Product Table 94. Novo Nordisk Revenue in Hemophilia Treatment Business (2016-2021) & (US$ Million) Table 95. Novo Nordisk Recent Development Table 96. Roche Company Details Table 97. Roche Business Overview Table 98. Roche Revenue in Hemophilia Treatment Business (2016-2021) & (US$ Million) Table 99. Roche Recent Development Table 100. Takeda Company Details Table 101. Takeda Business Overview Table 102. Takeda Hemophilia Treatment Product Table 103. Takeda Revenue in Hemophilia Treatment Business (2016-2021) & (US$ Million) Table 104. Takeda Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Hemophilia Treatment Market Share by Type: 2020 VS 2027 Figure 2. On-demand Features Figure 3. Prophylaxis Features Figure 4. Global Hemophilia Treatment Market Share by Application: 2020 VS 2027 Figure 5. Replacement Therapy Case Studies Figure 6. ITI Therapy Case Studies Figure 7. Gene Therapy Case Studies Figure 8. Hemophilia Treatment Report Years Considered Figure 9. Global Hemophilia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Hemophilia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Hemophilia Treatment Market Share by Regions: 2020 VS 2027 Figure 12. Global Hemophilia Treatment Market Share by Regions (2022-2027) Figure 13. Global Hemophilia Treatment Market Share by Players in 2020 Figure 14. Global Top Hemophilia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Treatment as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Hemophilia Treatment Revenue in 2020 Figure 16. Global Hemophilia Treatment Revenue Market Share by Type (2016-2021) Figure 17. Global Hemophilia Treatment Revenue Market Share by Type (2022-2027) Figure 18. North America Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Hemophilia Treatment Market Share by Type (2016-2027) Figure 20. North America Hemophilia Treatment Market Share by Application (2016-2027) Figure 21. North America Hemophilia Treatment Market Share by Country (2016-2027) Figure 22. United States Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Hemophilia Treatment Market Share by Type (2016-2027) Figure 26. Europe Hemophilia Treatment Market Share by Application (2016-2027) Figure 27. Europe Hemophilia Treatment Market Share by Country (2016-2027) Figure 28. Germany Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Hemophilia Treatment Market Share by Type (2016-2027) Figure 36. Asia-Pacific Hemophilia Treatment Market Share by Application (2016-2027) Figure 37. Asia-Pacific Hemophilia Treatment Market Share by Region (2016-2027) Figure 38. China Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Hemophilia Treatment Market Share by Type (2016-2027) Figure 46. Latin America Hemophilia Treatment Market Share by Application (2016-2027) Figure 47. Latin America Hemophilia Treatment Market Share by Country (2016-2027) Figure 48. Mexico Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Hemophilia Treatment Market Share by Type (2016-2027) Figure 52. Middle East & Africa Hemophilia Treatment Market Share by Application (2016-2027) Figure 53. Middle East & Africa Hemophilia Treatment Market Share by Country (2016-2027) Figure 54. Turkey Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Hemophilia Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. CSL Behring Revenue Growth Rate in Hemophilia Treatment Business (2016-2021) Figure 58. Baxalta Revenue Growth Rate in Hemophilia Treatment Business (2016-2021) Figure 59. Pfizer Inc Revenue Growth Rate in Hemophilia Treatment Business (2016-2021) Figure 60. BioMarin Revenue Growth Rate in Hemophilia Treatment Business (2016-2021) Figure 61. Bayer Healthcare Revenue Growth Rate in Hemophilia Treatment Business (2016-2021) Figure 62. Biogen Revenue Growth Rate in Hemophilia Treatment Business (2016-2021) Figure 63. Novo Nordisk Revenue Growth Rate in Hemophilia Treatment Business (2016-2021) Figure 64. Roche Revenue Growth Rate in Hemophilia Treatment Business (2016-2021) Figure 65. Takeda Revenue Growth Rate in Hemophilia Treatment Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

CSL Behring Baxalta Pfizer Inc BioMarin Bayer Healthcare Biogen Novo Nordisk Roche Takeda